论文部分内容阅读
根据胸腺细胞调节免疫功能的机理,利用胎儿胸腺细胞治疗再生障碍性贫血、肿瘤及其它一些疾病,临床长期应用无副作用,国内外已有不少报道。我们自1987年5月以来,用胎儿胸腺细胞悬液(TCS)有选择性的治疗某些眼病30例,取得了较好的疗效,现报告如下: 材料与方法一、胎儿胸腺细胞悬液的制备:采用3.5～7个月的水囊引产无畸形胎儿,无菌条件下解剖取胸腺,常规制备单细胞液,调浓度到1×10~6个/ml,冰箱4℃保存备用。存放时间不超过36小时,注射时细胞活度在70％
According to thymocyte regulation of immune function mechanism, the use of fetal thymocytes in the treatment of aplastic anemia, cancer and other diseases, clinical long-term use of no side effects, there have been many reports at home and abroad. We since May 1987, with fetal thymocyte suspension (TCS) in the selective treatment of 30 cases of certain eye diseases, and achieved good results, are reported as follows: Materials and Methods First, fetal thymocyte suspension Preparation: Using 3.5 to 7 months of induction of labor unvulnerable fetal water sac, under the aseptic conditions to take the thymus, routine preparation of single cell liquid, adjust the concentration to 1 × 10 ~ 6 / ml, 4 ℃ refrigerator spare. Storage time does not exceed 36 hours, cell activity at injection of 70%